The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis
- 30 November 2000
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 94 (11) , 1029-1037
- https://doi.org/10.1053/rmed.2000.0927
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Risk factors for lower airway bacterial colonization in chronic bronchitisEuropean Respiratory Journal, 1999
- Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.European Respiratory Journal, 1999
- In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistanceClinical Therapeutics, 1998
- Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance ProgramClinical Infectious Diseases, 1998
- Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory seasonDiagnostic Microbiology and Infectious Disease, 1997
- Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tractThe American Journal of Medicine, 1995
- Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.American Journal of Respiratory and Critical Care Medicine, 1995
- Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary diseaseThe American Journal of Medicine, 1995
- Antibiotics in Chronic Obstructive Pulmonary Disease ExacerbationsJAMA, 1995
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987